BG60833B2 - Теофилин-лекарствена форма с удължено действие - Google Patents

Теофилин-лекарствена форма с удължено действие Download PDF

Info

Publication number
BG60833B2
BG60833B2 BG098598A BG9859894A BG60833B2 BG 60833 B2 BG60833 B2 BG 60833B2 BG 098598 A BG098598 A BG 098598A BG 9859894 A BG9859894 A BG 9859894A BG 60833 B2 BG60833 B2 BG 60833B2
Authority
BG
Bulgaria
Prior art keywords
theophylline
dosage form
matrix pellets
pellets
matrix
Prior art date
Application number
BG098598A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gerald Benedikt
Volker Steinijans
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BG60833B2 publication Critical patent/BG60833B2/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
BG098598A 1984-12-21 1994-02-28 Теофилин-лекарствена форма с удължено действие BG60833B2 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH611184 1984-12-21
CH268385 1985-06-24

Publications (1)

Publication Number Publication Date
BG60833B2 true BG60833B2 (bg) 1996-04-30

Family

ID=25691137

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098598A BG60833B2 (bg) 1984-12-21 1994-02-28 Теофилин-лекарствена форма с удължено действие

Country Status (20)

Country Link
US (1) US4803080A (cs)
EP (1) EP0185331B1 (cs)
KR (1) KR920006910B1 (cs)
CN (1) CN1008060B (cs)
AU (1) AU581274B2 (cs)
BG (1) BG60833B2 (cs)
CA (1) CA1261268A (cs)
CS (1) CS396391A3 (cs)
DE (1) DE3572924D1 (cs)
DK (1) DK164843C (cs)
ES (1) ES8704079A1 (cs)
FI (1) FI84782C (cs)
GR (1) GR853051B (cs)
HU (1) HU193359B (cs)
IE (1) IE58246B1 (cs)
IL (1) IL77322A (cs)
NO (1) NO171827C (cs)
NZ (1) NZ214534A (cs)
PT (1) PT81714B (cs)
SK (1) SK278868B6 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
ZA200707250B (en) * 2005-01-27 2009-06-24 Alembic Ltd Extended release formulation of levetiracetam
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
EP2731599B1 (en) 2011-07-15 2018-10-31 NuSirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
BR112015010947A2 (pt) 2012-11-13 2018-06-05 Nusirt Sciences Inc composições e métodos para aumentar o metabolismo energético.
US20150359771A1 (en) 2013-01-15 2015-12-17 Nusirt Sciences, Inc. Treating pulmonary conditions
US9585876B2 (en) 2013-03-15 2017-03-07 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
CA2939833A1 (en) 2014-02-27 2015-09-03 Nusirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
US10633570B2 (en) * 2015-04-16 2020-04-28 The School Corporation Kansai University Anti-ice nucleation activator
CN106176682A (zh) * 2016-08-30 2016-12-07 铜陵翔宇商贸有限公司 茶碱缓释制胶囊剂及其制备方法
WO2020067887A1 (en) 2018-09-24 2020-04-02 Erasmus University Medical Center Rotterdam Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1172087A (fr) * 1956-01-25 1959-02-05 Bellon Labor Sa Roger Perfectionnements concernant l'enrobage de préparations à effet retardé et à effet soutenu
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
EP0083372B1 (en) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Sustained release theophyline
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung

Also Published As

Publication number Publication date
PT81714A (de) 1986-01-01
IE58246B1 (en) 1993-08-11
SK278868B6 (sk) 1998-04-08
DK164843C (da) 1993-01-11
ES550291A0 (es) 1987-04-01
NO171827C (no) 1993-05-12
FI84782C (fi) 1992-01-27
KR920006910B1 (ko) 1992-08-22
HU193359B (en) 1987-09-28
EP0185331A1 (de) 1986-06-25
NO171827B (no) 1993-02-01
CN1008060B (zh) 1990-05-23
IE853107L (en) 1986-06-21
HUT40334A (en) 1986-12-28
US4803080A (en) 1989-02-07
AU5161885A (en) 1986-07-17
GR853051B (cs) 1986-02-03
ES8704079A1 (es) 1987-04-01
DE3572924D1 (en) 1989-10-19
EP0185331B1 (de) 1989-09-13
FI84782B (fi) 1991-10-15
NO855215L (no) 1986-06-23
PT81714B (pt) 1988-04-21
AU581274B2 (en) 1989-02-16
CS396391A3 (en) 1992-06-17
KR860004634A (ko) 1986-07-11
DK600485D0 (da) 1985-12-20
CN85109688A (zh) 1986-06-10
DK164843B (da) 1992-08-31
NZ214534A (en) 1988-08-30
DK600485A (da) 1986-06-22
CA1261268A (en) 1989-09-26
FI854973A0 (fi) 1985-12-16
IL77322A (en) 1990-07-12
FI854973L (fi) 1986-06-22

Similar Documents

Publication Publication Date Title
BG60833B2 (bg) Теофилин-лекарствена форма с удължено действие
RU2201223C2 (ru) Фармацевтическая композиция из множества субъединиц и способ ее получения
CA2042289C (en) Taste masking and sustained release coatings for pharmaceuticals
JP4976011B2 (ja) 制御放出モルヒネ製剤
CA2038245C (en) Pharmaceutically useful micropellets
US5527545A (en) Liquid-suspension controlled-release pharmaceutical composition
US4717713A (en) Controlled release liquid pharmaceutical
US4443428A (en) Extended action controlled release compositions
JP3011770B2 (ja) 吸入適用のための製剤
US6149943A (en) Microcrystalline cellulose particles having active core
FR2494112A1 (cs)
JPH10502390A (ja) 医薬品用の徐放性マトリックス
US4966770A (en) Prednisone microencapsulated granules
EP0083372B1 (en) Sustained release theophyline
JPH082783B2 (ja) 新規な投与形態
US4656024A (en) Galenical administration form of METOCLOPRAMIDE, method for its preparation and medicament comprising the new form
CN115837012A (zh) 一种氨氯地平干混悬剂及其制备方法
JPH0417932B2 (cs)
US5344657A (en) Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
AU3415993A (en) Prolamine coatings for taste-masking orally-administrable medicaments
CA1336326C (en) Microbeads of diltiazem, a process for their manufacture and a sustained-release pharmaceutical composition containing them
JPH0474331B2 (cs)
US20130115282A1 (en) Polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
CN100420437C (zh) 磷酸川芎嗪缓释微丸及制备方法
CN111214454B (zh) 一种防止析晶的单硝酸异山梨酯缓释微丸及其制备方法